BIOCRYST PHARMACEUTICALS INC — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by BIOCRYST PHARMACEUTICALS INC (BCRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOCRYST PHARMACEUTICALS INC has filed 4 SCHEDULE 13G/A documents with the SEC since 2015. To view all SEC filings by BIOCRYST PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000742 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001193805-26-000127 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002355 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001576419-25-000567 | Apr 17, 2025 | — |